Grants per year
Personal profile
About
Dr. Bifulco is a Surgical Pathologist with additional fellowship subspecialty training, expertise, and board certification in Molecular Genetic Pathology and Hematopathology. Dr. Bifulco currently serves as Chief Medical Officer, Providence Genomics, and as Member and Director of Translational Molecular Pathology and Molecular Genomics at the Earle A. Chiles Research Institute in Portland, Oregon, a division of Providence Cancer Institute. He oversees Providence Molecular Genomics Laboratory, one of the largest clinical genomics labs in the Pacific Northwest, which provides state-of-the-art genomic sequencing to cancer patients across the seven state PSJH system.
Prior to joining Providence, Dr. Bifulco served on the Pathology faculty at Yale University and completed fellowships in Oncologic Surgical Pathology and Molecular Genetic Pathology at Memorial Sloan Kettering Cancer Center. His current translational research is focused on supporting the characterization of the tumor immune microenvironment through immunohistochemical and image analysis techniques, and on the integration of genomics with immunotherapies. Dr. Bifulco serves on the Global Colon Cancer Immunoscore Task Force led by the Society for Immunotherapy of Cancer (SITC), and is Co-Chair of the SITC Pathology Task Force convened to establish multiplexed immunohistochemistry/ immunofluorescence (mIHC/IF) standards.
Education/Academic qualification
Memorial Sloan Kettering Cancer Center
State University of Milan, Italy
Yale University
Yale-New Haven Hospital
External positions
Director, Providence Portland Medical Center
Jan 1 2011 → Jan 1 2019
Director, Providence Portland Medical Center
Jan 1 2011 → Jan 1 2019
NCCCP Biospecimens, Co-Lead, Providence Portland Medical Center
Jan 1 2010 → Jan 1 2012
NCCCP Biospecimens, Co-Lead, Providence Portland Medical Center
Jan 1 2010 → Jan 1 2012
Attending, Providence Portland Medical Center
Jan 1 2008 → …
Attending, Providence Portland Medical Center
Jan 1 2008 → …
Director, Yale University
Jan 1 2006 → Jan 1 2008
Assistant Professor, University of Florida
Jan 1 2003
Assistant Professor, University of Florida
Jan 1 2003
Assistant Professor, Yale University
Jan 1 2003 → Jan 1 2007
Assistant Professor, Yale University
Jan 1 2003 → Jan 1 2007
Director, National Cancer Institute, Milan, Italy
Jan 1 2001 → Jan 1 2002
Director, National Cancer Institute, Milan, Italy
Jan 1 2001 → Jan 1 2002
Attending, National Cancer Institute, Milan, Italy
Jan 1 2000 → Jan 1 2002
Attending, National Cancer Institute, Milan, Italy
Jan 1 2000 → Jan 1 2002
Fingerprint
Dive into the research topics where Carlo Bifulco is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 10 Finished
-
Applying machine learning techniques on routinely collected breast cancer data to improve patient outcomes
01/1/20 → 01/1/21
Project: Research
-
-
Multispectral IHC to delineate the tumor environment in AML and monitor fluctuations with flotetuzumab
01/1/18 → 01/1/23
Project: Research
-
Intra-Tumor IO: in vivo screening platform for Head and Neck Cancer
01/1/16 → 01/1/20
Project: Research
-
FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
Knorr, D. A., Blanchard, L., Leidner, R. S., Jensen, S. M., Meng, R., Jones, A., Ballesteros-Merino, C., Bell, R. B., Baez, M., Marino, A., Sprott, D., Bifulco, C. B., Piening, B., Dahan, R., Osorio, J. C., Fox, B. A. & Ravetch, J. V., Mar 4 2024, In: Cancer Immunology Research. 12, 3, p. 322-333 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
SITC Clinical Immuno-Oncology Network (SCION) commentary on measurement and interpretation of essential biomarkers in early clinical trials
Lotze, M. T., Cottrell, T., Bifulco, C., Chow, L., Cope, L., Gnjatic, S., Maecker, H. T. & Shen, J. Y. P., Mar 21 2024, In: Journal for ImmunoTherapy of Cancer. 12, 3, e008655.Research output: Contribution to journal › Review article › peer-review
Open Access -
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer
Mlecnik, B., Lugli, A., Bindea, G., Marliot, F., Bifulco, C., Lee, J. K. J., Zlobec, I., Rau, T. T., Berger, M. D., Nagtegaal, I. D., Vink-Börger, E., Hartmann, A., Geppert, C. I., Kolwelter, J., Merkel, S., Grützmann, R., Van den Eynde, M., Jouret-Mourin, A., Kartheuser, A., Léonard, D., & 71 others, Jan 2023, In: Cancers. 15, 2, 418.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Multi-Institutional Evaluation of Pathologists’ Assessment Compared to Immunoscore
Willis, J., Anders, R. A., Torigoe, T., Hirohashi, Y., Bifulco, C., Zlobec, I., Mlecnik, B., Demaria, S., Choi, W. T., Dundr, P., Tatangelo, F., Di Mauro, A., Baldin, P., Bindea, G., Marliot, F., Haicheur, N., Fredriksen, T., Kirilovsky, A., Buttard, B., Vasaturo, A., & 11 others, Aug 2023, In: Cancers. 15, 16, 4045.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)
Ascierto, P. A., Avallone, A., Bifulco, C., Bracarda, S., Brody, J. D., Emens, L. A., Ferris, R. L., Formenti, S. C., Hamid, O., Johnson, D. B., Kirchhoff, T., Klebanoff, C. A., Lesinski, G. B., Monette, A., Neyns, B., Odunsi, K., Paulos, C. M., Powell, D. J., Rezvani, K., Segal, B. H., & 4 others, Dec 2023, In: Journal of Translational Medicine. 21, 1, 488.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations